Applied Genetic Technologies Corp (NASDAQ:AGTC) gets upgraded to Outperform by BMO Capital Markets with a price target of $9.00

Analyst Ratings For Applied Genetic Technologies Corp (NASDAQ:AGTC)

Story continues below

Today, Applied Genetic Technologies Corp (NASDAQ:AGTC) stock received an upgrade by BMO Capital Markets from Market Perform to Outperform with a price target of $9.00.

There are 6 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Applied Genetic Technologies Corp (NASDAQ:AGTC) is Buy with a consensus target price of $12.25 per share, a potential 206.25% upside.

Some recent analyst ratings include

  • 9/27/2019-Applied Genetic Technologies Corp (NASDAQ:AGTC) gets upgraded to Outperform by BMO Capital Markets with a price target of $9.00
  • 9/23/2019-Applied Genetic Technologies Corp (NASDAQ:AGTC) had its Buy rating reiterated by HC Wainwright with a $18.00 price target
  • 9/6/2019-Applied Genetic Technologies Corp (NASDAQ:AGTC) has coverage initiated with a Buy rating and $13.00 price target
  • 9/3/2019-Applied Genetic Technologies Corp (NASDAQ:AGTC) gets upgraded to Buy by Chardan Capital with a price target of $7.50
  • 5/8/2019-Applied Genetic Technologies Corp (NASDAQ:AGTC) had its Outperform rating reiterated by Wedbush with a $11.00 price target
  • 1/17/2018-Applied Genetic Technologies Corp (NASDAQ:AGTC) had its Hold rating reiterated by Cantor Fitzgerald with a $9.00 price target
  • On 12/14/2018 Susan B Washer, Insider, bought 2,380 with an average share price of $3.34 per share and the total transaction amounting to $7,949.20.
  • On 12/14/2018 William A. Sullivan, CFO, bought 3,000 with an average share price of $3.33 per share and the total transaction amounting to $9,990.00.
  • On 12/14/2018 William Aliski, Director, bought 6,000 with an average share price of $3.25 per share and the total transaction amounting to $19,500.00.
  • On 11/16/2016 Ivana Magovcevic, Director, bought 3,000 with an average share price of $9.63 per share and the total transaction amounting to $28,890.00.
  • On 11/1/2016 Jeffrey D Chulay, VP, sold 1,000 with an average share price of $7.05 per share and the total transaction amounting to $7,050.00.
  • On 9/22/2016 Mark S Shearman, Insider, bought 3,000 with an average share price of $8.87 per share and the total transaction amounting to $26,610.00.
  • On 9/20/2016 Stephen W Potter, Insider, bought 1,400 with an average share price of $8.89 per share and the total transaction amounting to $12,446.00.

Recent Trading Activity for Applied Genetic Technologies Corp (NASDAQ:AGTC)
Shares of Applied Genetic Technologies Corp closed the previous trading session at 4.00 up +0.22 5.82% with 3.7 shares trading hands.

An ad to help with our costs